AFP and testicular cancer: A recent review made the following conclusion: “Having systematically reviewed the available literature, we found surprisingly little evidence to guide optimal testing with biomarkers (AFP, hCG and LDH) routinely used during follow-up for testicular cancer recurrence” [65].